These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24469938)

  • 21. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
    Tsuneki H; Wada T; Sasaoka T
    Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.
    Sharf R; Sarhan M; Brayton CE; Guarnieri DJ; Taylor JR; DiLeone RJ
    Biol Psychiatry; 2010 Apr; 67(8):753-60. PubMed ID: 20189166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocretins (orexins): The ultimate translational neuropeptides.
    Jacobson LH; Hoyer D; de Lecea L
    J Intern Med; 2022 May; 291(5):533-556. PubMed ID: 35043499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orexin A and B in vitro modify orexins receptors expression and gonadotropins secretion of anterior pituitary cells of proestrous rats.
    Cataldi NI; Lux Lantos VA; Libertun C
    Regul Pept; 2014 Jan; 188():25-30. PubMed ID: 24333629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors.
    Mieda M; Yanagisawa M
    Curr Opin Neurobiol; 2002 Jun; 12(3):339-45. PubMed ID: 12049942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis.
    Sakurai T
    CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):313-25. PubMed ID: 16787231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of hypothalamic orexin in drug addiction].
    Han J; Li YH; Bai YJ; Sui N
    Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):327-30. PubMed ID: 18232303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of hypocretins/orexins in sleep disorders and narcolepsy.
    Brown RE
    Drug News Perspect; 2003 Mar; 16(2):75-9. PubMed ID: 12792667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of suvorexant.
    Stahl SM
    CNS Spectr; 2016 Jun; 21(3):215-8. PubMed ID: 27322687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
    Irukayama-Tomobe Y; Ogawa Y; Tominaga H; Ishikawa Y; Hosokawa N; Ambai S; Kawabe Y; Uchida S; Nakajima R; Saitoh T; Kanda T; Vogt K; Sakurai T; Nagase H; Yanagisawa M
    Proc Natl Acad Sci U S A; 2017 May; 114(22):5731-5736. PubMed ID: 28507129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
    Xu TR; Yang Y; Ward R; Gao L; Liu Y
    Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice.
    Yukitake H; Fujimoto T; Ishikawa T; Suzuki A; Shimizu Y; Rikimaru K; Ito M; Suzuki M; Kimura H
    Pharmacol Biochem Behav; 2019 Dec; 187():172794. PubMed ID: 31654653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease.
    Cabanas M; Pistono C; Puygrenier L; Rakesh D; Jeantet Y; Garret M; Cho YH
    Neurotherapeutics; 2019 Jul; 16(3):784-796. PubMed ID: 30915710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To eat or to sleep? Orexin in the regulation of feeding and wakefulness.
    Willie JT; Chemelli RM; Sinton CM; Yanagisawa M
    Annu Rev Neurosci; 2001; 24():429-58. PubMed ID: 11283317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OX2R-selective orexin agonism is sufficient to ameliorate cataplexy and sleep/wake fragmentation without inducing drug-seeking behavior in mouse model of narcolepsy.
    Yamamoto H; Nagumo Y; Ishikawa Y; Irukayama-Tomobe Y; Namekawa Y; Nemoto T; Tanaka H; Takahashi G; Tokuda A; Saitoh T; Nagase H; Funato H; Yanagisawa M
    PLoS One; 2022; 17(7):e0271901. PubMed ID: 35867683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orexins and the treatment of obesity.
    Smart D; Haynes AC; Williams G; Arch JR
    Eur J Pharmacol; 2002 Apr; 440(2-3):199-212. PubMed ID: 12007536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle.
    Salin-Pascual RJ
    Isr Med Assoc J; 2001 Feb; 3(2):144-6. PubMed ID: 11344826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Subthalamic Neurons are Activated by Both Orexin-A and Orexin-B.
    Sheng Q; Xue Y; Wang Y; Chen AQ; Liu C; Liu YH; Chu HY; Chen L
    Neuroscience; 2018 Jan; 369():97-108. PubMed ID: 29138106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice.
    Akiyama M; Yuasa T; Hayasaka N; Horikawa K; Sakurai T; Shibata S
    Eur J Neurosci; 2004 Dec; 20(11):3054-62. PubMed ID: 15579160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orexins excite ventrolateral geniculate nucleus neurons predominantly via OX2 receptors.
    Chrobok L; Palus K; Lewandowski MH
    Neuropharmacology; 2016 Apr; 103():236-46. PubMed ID: 26724374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.